StimAire, a paradigm-shifting injectable neuromodulation company developing medical devices for obstructive sleep apnea (OSA), is pleased to be recognized in the Top 5 Most Compelling Innovators out of 400 companies by Life Sciences Innovation (LSI) USA, March 2026.

LSI is the world’s largest accelerator for life sciences startup companies, linking emerging innovation with ventures capitalists, strategic investors, and private equity.

“LSI was founded to help today’s executives build, finance, and scale tomorrow’s medical innovations. Today, we’re building something transformative: a global platform to access capital, insights, and expertise. One connected ecosystem of premium experiences, data solutions, and media that enables the industry to act smarter, faster, and with more impact. The future of healthcare will be built by those with the right relationships and the best intelligence, and LSI is leading the way to unlock it.” LSI Website

https://www.linkedin.com/posts/lsicompassai_with-400-startups-presenting-identifying-activity-7444421917828100096-7Wv6?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAklUPwBo17qSga1HJ-8KVUWMHEydlk70nc

Contact:
Tarek Makansi PhD
CEO
StimAire
tmakansi@stimaire.com
1-520-360-0823